Skip to main content

Kevin McLaughlin

Equibles does not estimate personal net worth.

Get an email with a short summary when Vericel Corp publishes a filing, an earnings call transcript or a press release.

Get VCEL alerts

About Kevin McLaughlin

Kevin McLaughlin is recorded as Board Member at Vericel Corp (VCEL) since April 30, 2025. Vericel Corp reported in an 8-K filed May 2, 2025 that Kevin McLaughlin was appointed director, effective April 30, 2025. Vericel Corp reported in an 8-K filed May 5, 2023 that Kevin McLaughlin was appointed director, effective May 3, 2023. Vericel Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vericel Corp includes Joseph A. Mara (CFO), Michael Halpin (COO), Sean C. Flynn (General Counsel) and 7 others.

“the election of each of Robert Zerbe, Alan Rubino, Heidi Hagen, Kevin McLaughlin, Paul Wotton, Lisa Wright and Dominick Colangelo as a director of the Company to serve for a one-year term expiring at the Company's 2026 annual meeting of shareholders and until his or her successor has been elected and qualified”
Vericel Corp Form 8-K, filed May 2, 2025 · Read the filing
“the election of each of Robert Zerbe, Alan Rubino, Heidi Hagen, Steven Gilman, Kevin McLaughlin, Paul Wotton, Lisa Wright and Dominick Colangelo as a director of the Company to serve for a one-year term expiring at the Company’s 2024 annual meeting of shareholders and until his or her successor has been elected and qualified”
Vericel Corp Form 8-K, filed May 5, 2023 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2025-04-30–present

Leadership on record at Vericel Corp

Recent activity